Loading...
Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients
OBJECTIVE: Fingolimod is approved for the treatment of highly active relapsing remitting multiple sclerosis (MS) patients and acts by its unique mechanism of action via sphingosine-1-phosphate receptor-modulation. Although fingolimod-associated lymphopenia is a well-known phenomenon, the exact cause...
Saved in:
| Published in: | Front Immunol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256977/ https://ncbi.nlm.nih.gov/pubmed/30524432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|